Department of Pharmacy Xuanwu Hospital of Capital Medical University Beijing Institute for Brain Disorders Beijing Engineering Research Center for Nerve System Drugs Key Laboratory for Neurodegenerative Diseases of Ministry of Education Beijing 100053 China;
Department of Pharmacy Xuanwu Hospital of Capital Medical University Beijing Institute for Brain Disorders Beijing Engineering Research Center for Nerve System Drugs Key Laboratory for Neurodegenerative Diseases of Ministry of Education Beijing 100053 China;
Department of Pharmacy Xuanwu Hospital of Capital Medical University Beijing Institute for Brain Disorders Beijing Engineering Research Center for Nerve System Drugs Key Laboratory for Neurodegenerative Diseases of Ministry of Education Beijing 100053 China;
Department of Pharmacy Xuanwu Hospital of Capital Medical University Beijing Institute for Brain Disorders Beijing Engineering Research Center for Nerve System Drugs Key Laboratory for Neurodegenerative Diseases of Ministry of Education Beijing 100053 China;
State Key Laboratory of Cognitive Neuroscience and Learning&IDG/McGovern Institute for Brain Research Beijing Normal University Beijing 100875 ChinaBABRI Centre Beijing Normal University Beijing 100875 China;
Department of Pharmacy Xuanwu Hospital of Capital Medical University Beijing Institute for Brain Disorders Beijing Engineering Research Center for Nerve System Drugs Key Laboratory for Neurodegenerative Diseases of Ministry of Education Beijing 100053 China;
Department of Pharmacy Xuanwu Hospital of Capital Medical University Beijing Institute for Brain Disorders Beijing Engineering Research Center for Nerve System Drugs Key Laboratory for Neurodegenerative Diseases of Ministry of Education Beijing 100053 China;
Aβ; Alzheimer’s disease; APP/PS1; inflammation; neuronal loss; Shenqi Xingnao Granules; tau phosphorylation;